Lymphadenopathy in rheumatic patients.

Area of Science:

• Rheumatology
• Pathology
• Immunology

Background:

• Lymph node enlargement is a common clinical finding.
• Distinguishing reactive lymphadenopathy from lymphoma is critical for patient management.
• Chronic inflammatory conditions can present with lymphadenopathy.

Purpose of the Study:

• To investigate the histological and clinical features of lymph node biopsies in patients with chronic inflammatory joint disease.
• To assess the diagnostic accuracy of lymph node biopsies in differentiating reactive changes from malignancy.
• To explore the association between lymphadenopathy and the development of inflammatory polyarthritis.

Main Methods:

• Histological examination of lymph node biopsy specimens from 22 patients.
• Immunoperoxidase staining for immunoglobulins, macrophage markers, and surface markers (MT1, MB1).
• Clinical review and follow-up of patients to assess disease course and development of inflammatory polyarthritis.

Main Results:

• No evidence of malignant lymphoma was found in any of the biopsy specimens, despite initial concerns in two patients.
• Histological features and clinical information were essential for accurate diagnosis.
• Lymphadenopathy was identified as a potential early sign of inflammatory polyarthritis.
• 20% of patients with unexplained reactive lymphadenopathy developed inflammatory polyarthropathy within one year.

Conclusions:

• Accurate diagnosis of lymph node enlargement in chronic inflammatory joint disease requires careful histological assessment and clinical correlation.
• Reactive lymphadenopathy can precede or accompany inflammatory polyarthritis.
• Lymph node biopsy plays a vital role in excluding malignancy and identifying inflammatory causes of lymphadenopathy.